Latest Regulatory News

Auris Minerals Limited has been queried by the ASX following a sharp rise in its share price and trading volume, with the company denying any undisclosed information behind the surge.

Medallion Metals Limited has opened a Share Purchase Plan offering eligible shareholders in Australia and New Zealand the chance to buy shares at a 20.8% discount, aiming to raise $5 million for advancing its Forrestania and Cosmic Boy projects.

Temas Resources has fortified its position in the critical minerals sector through key strategic moves including joining Québec’s CSM Scientific Network, engaging market-making services, and commissioning independent equity research.

BlinkLab Limited has secured independent scientific validation for its smartphone-based autism diagnostic technology through publication in the prestigious journal Autism Research, marking a significant milestone ahead of its FDA regulatory trial.

Island Pharmaceuticals reports ongoing FDA review of its antiviral Galidesivir, with no adverse feedback received as the regulator takes extra time to finalise guidance.

New Frontier Minerals has moved its Mining Lease Application for the Big One Copper Deposit into the technical assessment phase, marking a key step toward near-term development amid a strong copper market.

Renergen Limited and Asp Isotopes Inc. have outlined the process for cash payments to shareholders for fractional entitlements following their share acquisition scheme.

I Synergy Group Limited has announced a planned 5-for-1 consolidation of its ordinary shares and options, pending shareholder approval. The move aims to reduce the number of securities on issue, with trading of consolidated shares set to begin in early February.

Calix Limited has responded to an ASX price query following a notable rise in its share price and trading volume, confirming no undisclosed information and full compliance with listing rules.

Taiton Resources has completed the first tranche of its capital raising, issuing 3.38 million shares to sophisticated investors, with a larger tranche still pending. This move aims to bolster funding for its mineral exploration projects across South Australia and New South Wales.

Next Science Limited’s shares have been suspended from ASX trading due to insufficient ongoing operations following the disposal of its main business. The suspension raises questions about the company’s future direction and compliance with listing rules.

NT Minerals Limited has been suspended from ASX trading due to failure to meet operational requirements, raising questions about its future viability.